Peripheral Artery Disease Market – Global Opportunity Analysis and Industry Forecast 2020-2030 – ResearchAndMarkets.com

DUBLIN – (BUSINESS WIRE) – Added Peripheral Arterial Disease Market by Type, Global Opportunity Analysis, Industry Forecast, 2020-2030 report, added. ResearchAndMarkets.com to offer.

With an estimated value of over $ 4.53 billion in 2019, the global peripheral arterial disease market is forecast to have a CAGR of 6.2% and over $ 8.78 billion in the forecast year 2020-2030 thrive.

Peripheral artery disease is a common circulatory problem that causes the peripheral arteries to narrow. Generally, it affects the arteries in the legs and sometimes the arteries that carry blood from the heart to the arms, kidneys, head, and stomach. It is mainly caused by the build-up of fats or plaques on the walls of the arteries. Exercise, smoking cessation, and a healthy diet are the main treatments for this disease; However, when such treatments are not enough, medication or surgery can help.

Market dynamics and trends:

Factors such as a large geriatric population, widespread unhealthy lifestyle habits, and rising approvals of new products in the field of peripheral arterial disease are driving the growth of the market. In addition, high risk factors such as diabetes and smoking are contributing to the rising incidences of peripheral arterial disease and driving market growth further.

However, concerns about restenosis, the recurrence of peripheral arterial occlusive disease (PAD) even after treatment, may hamper the growth of the market to some extent. On the other hand, constantly changing lifestyle habits such as unhealthy eating habits, excessive alcohol consumption, and lack of physical activity also make PAD more susceptible to PAD, thus promoting market growth.

Geographical Analysis:

Geographically, North America had a large market share in 2019. This is due to higher healthcare spending and the increasing incidence of minimally invasive surgery in the region.

However, the Asia Pacific region is expected to be the fastest growing market due to the large patient pool and unmet medical need. In addition, significant population growth along with a growing geriatric population is expected to be opportunistic for market growth in this region during the forecast period.

Competitive landscape:

Lucrative growth opportunities make the peripheral arterial disease market highly competitive. Some of the major players in the market are Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Terumo Corporation, Cook Medical, Becton, Dickinson and Company, Koninklijke Philips NV, AngioDynamics, Inc., BIOTRONIK and B. Braun Melsungen AG. and many more.

A number of corporate development strategies have been adopted in recent years. For example, in September 2020 Abbott Laboratories started the LIFE-BTK clinical trial to evaluate the efficacy and safety of its Esprit BTK Everolimus Eluting Resorbable Scaffold System. This is the US Investigational Device Exemption (IDE) study, which is expected to help people fight the advanced stages of peripheral arterial disease (PAOD).

In addition, Becton, Dickinson and Company acquired Straub Medical AG, a private company, in June 2020. Straub Medical AG develops medical devices for atherectomy and thrombectomy for the treatment of venous diseases and peripheral arterial occlusive diseases (PAOD). This acquisition strengthens the capabilities of Becton, Dickinson and Company to treat diseases of the peripheral arteries.

Key topics covered:

1 Introduction

1.1. Report description

1.2. Research methodology

2. Market Overview, 2019-2030 MILLION USD

2.1. Market snapshot

3. Porter’s Five Forces Model Analysis

4. Market dynamics

4.1. Growth accelerator

4.2. Challenges

4.3. opportunities

5. Global Peripheral Arterial Disease Market By Type

5.1. overview

5.2. Balloons for peripheral angioplasty

5.2.1 Global Peripheral Angioplasty Balloons Market By Type

5.2.1.1 Market for old / normal balloons

5.2.1.2 Cutting and Scoring Balloons Market

5.2.1.3 Drug Coated Balloon Market

5.2.2 Peripheral Angioplasty Balloons Market

5.3. Peripheral stents

5.3.1 Global Peripheral Stents Market By Type

5.3.1.1 Self-Expanding Market

5.3.1.2 Balloon Expandable Market

5.3.1.3 Covered Stent Market

5.3.1.4 Drug Eluting Stents Market

5.3.2 Peripheral Stent Market

5.4. Peripheral catheters

5.4.1 Global Peripheral Catheters Market By Type

5.4.1.1 Angiography Catheter Market

5.4.1.2 Market for guide catheters

5.4.2 Peripheral Catheter Market

5.5. Filters for Inferior Vena Cava (Ivc)

5.5.1 Global Inferior Vena Cava (Ivc) Filters Market By Type

5.5.1.1 Permanent Filters Market

5.5.1.2 On-Demand Filters Market

5.5.2 Inferior Vena Cava (Ivc) Filter Market

5.6. Plaque modification devices

5.6.1 Global Plaque Modification Devices Market By Type

5.6.1.1 Thrombectomy Devices Market

5.6.1.2 Atherectomy Devices Market

5.6.2 Plaque Modification Device Market

6. Global Peripheral Arterial Disease Market by Region

6.1. overview

7. Company profiles

• Abbott Laboratories

• Boston Scientific Corporation

• Cardinal Health, Inc.

• Terumo Corporation

• Cook medicine

• Becton, Dickinson and Company

• Royal Philips NV

• AngioDynamics, Inc.

• BIOTRONICS,

• B. Braun Melsungen AG.

Please visit https://www.researchandmarkets.com/r/vt52mg for more information on this report

source https://dailyhealthynews.ca/peripheral-artery-disease-market-global-opportunity-analysis-and-industry-forecast-2020-2030-researchandmarkets-com/